Default: Annals of Medicine

ISSN: 0785-3890

Journal Home

Journal Guideline

Annals of Medicine Q1 Unclaimed

Informa Healthcare United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Annals of Medicine is a journal indexed in SJR in Medicine (miscellaneous) with an H index of 112. It has a price of 2395 €. It has an SJR impact factor of 1,15 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,15.

Annals of Medicine focuses its scope in these topics and keywords: disease, mortality, patients, bone, cutaneous, damageprevention, coronary, controlled, complications, comparison, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

2395 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Annals of Medicine

1,15

SJR Impact factor

112

H Index

50

Total Docs (Last Year)

193

Total Docs (3 years)

2883

Total Refs

798

Total Cites (3 years)

186

Citable Docs (3 years)

3,58

Cites/Doc (2 years)

57,66

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


disease, mortality, patients, bone, cutaneous, damageprevention, coronary, controlled, complications, comparison, collaboration, death, developing, diabetes, diet, diseases, disordersinflammatory, drugs, cohort, coagulopathyare, ckdepi, allcause, arthritis, associations, attenuates, bathing, biomarkers, bitesmechanobiology, cardiac, cardiorespiratory, cardiovascular, casecontrol, cells, chronic, circadian,



Best articles by citations

Insulin-like Growth Factors, Their Receptors and Binding Proteins: Increasing Complexity

View more

Complement activation in Puumala hantavirus infection correlates with disease severity

View more

An insight into molecular mechanisms of human T helper cell differentiation

View more

In silico approaches to microarray-based disease classification and gene function discovery

View more

Predictive value of midregional pro-adrenomedullin compared to natriuretic peptides for incident cardiovascular disease and heart failure in the population-based FINRISK 1997 cohort

View more

Arterial elasticity and oxidized LDL among men with metabolic syndrome and different 10-year cardiovascular risk estimated by FINRISK and SCORE models

View more

Melanopsin: a novel photopigment involved in the photoentrainment of the brain's biological clock?

View more

Is liver disease a threat to patients with metabolic disorders?

View more

Early initiation of treatment with statins in acute coronary syndromes

View more

Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation

View more

Cytokines in Rheumatoid Arthritis

View more

Features of ST segment and T-wave in exercise-induced myocardial ischemia evaluated with multichannel magnetocardiography

View more
SHOW MORE ARTICLES

Sleep duration and insulin resistance in individuals without type 2 diabetes: The PPP-Botnia Study

View more

Neuregulin 1 and schizophrenia

View more

Assessment of response to therapy in hepatocellular carcinoma

View more

Fatality of myocardial infarction in relation to the coronary anatomy: role of culprit lesion location

View more

Hypertension predisposes to the formation of saccular intracranial aneurysms in 467 unruptured and 1053 ruptured patients in Eastern Finland

View more

Collagens and their Abnormalities in a Wide Spectrum of Diseases

View more

Stroke in diabetic and non-diabetic patients: Course and prognostic value of admission serum glucose

View more

Management and treatment of chronic hepatitis B in HIV-positive patients

View more

A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland

View more

New treatment strategies for disseminated intravascular coagulation based on current understanding of the pathophysiology

View more

Association of sleep-disordered breathing with diabetes-associated kidney disease

View more

The infant growth of boys who later develop coronary heart disease

View more

FAQS